Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$126.5K
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 15 most recent Form 4 transactions.
| Feb 3 | TNGX | Tango Therapeutics, Inc. | SSELL | 113 | $12.90 | $1.5K | <0.1% | Open the original filing on SEC.gov |
| Feb 3 | TNGX | Tango Therapeutics, Inc. | SSELL | 10,204 | $12.26 | $125.1K | -5.2% | Open the original filing on SEC.gov |
| Feb 2 | TNGX | Tango Therapeutics, Inc. | AGRANT◆ | 265,980 | — | — | — | Open the original filing on SEC.gov |
| Feb 2 | TNGX | Tango Therapeutics, Inc. | AGRANT | 44,330 | — | — | +29.5% | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 4,570 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 5,300 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 5,300 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS◆ | 7,000 | — | — | — | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | UTENDR | 10,842 | — | — | -100.0% | Open the original filing on SEC.gov |
| Jul 17, 2025 | BPMC | Blueprint Medicines Corp | DTOISS | 3,902 | — | — | -26.5% | Open the original filing on SEC.gov |
| Jun 18, 2025 | BPMC | Blueprint Medicines Corp | AGRANT | 3,902 | $128.12 | $499.9K | +36.0% | Open the original filing on SEC.gov |
| Jun 10, 2025 | UPB | Upstream Bio, Inc. | AGRANT◆ | 17,096 | — | — | — | Open the original filing on SEC.gov |
| May 22, 2025 | VOR | Vor Biopharma Inc. | AGRANT◆ | 30,000 | — | — | — | Open the original filing on SEC.gov |